Ignite Creation Date:
2026-03-26 @ 3:20 PM
Ignite Modification Date:
2026-04-01 @ 11:04 AM
Study NCT ID:
NCT07372118
Status:
COMPLETED
Last Update Posted:
2026-01-28
First Post:
2026-01-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Bioequivalence Study to Compare Empagliflozin / Metformin 25 mg/ 1000 mg Extended-Release Tablet Versus Synjardy XR Tablets 25mg/1000mg in Fast Condition
Sponsor:
Humanis Saglık Anonim Sirketi
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-09-27
Start Date Type:
ACTUAL
Primary Completion Date:
2025-12-29
Primary Completion Date Type:
ACTUAL
Completion Date:
2026-01-07
Completion Date Type:
ACTUAL
First Submit Date:
2026-01-20
First Submit QC Date:
None
Study First Post Date:
2026-01-28
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2026-01-20
Last Update Post Date:
2026-01-28
Last Update Post Date Type:
ACTUAL